Overview
Hereditary primary clear cell renal cell carcinoma (ccRCC) is a form of kidney cancer linked to inherited gene mutations 1. Understanding these genetic predispositions is crucial for guiding screening and treatment decisions for affected individuals and their families 1.Diagnosis
Germline testing for inherited gene mutations should be considered in patients with suspected urologic tumor syndromes 1.
Knowledge of these mutations has implications for both patient and family member screening and treatment 1.Management
Germline testing can impact treatment decisions for patients and their families 1.Key Recommendations
Germline testing for patients with suspected urologic tumor syndromes should be considered 1. (Evidence: Expert opinion)
Knowledge of inherited gene mutations associated with urologic cancers has implications for screening and treatment decisions for patients and their families 1. (Evidence: Expert opinion)References
1 Gomella PT, Mark JR, Giri VN, Kelly WK, Gomella LG. Guidelines on Germline Testing for Urologic Tumor Syndromes. European urology focus 2022. link